Novalgin and Yellow jacket sting - a phase IV clinical study of FDA data
We study 8,822 people who take Novalgin or have Yellow jacket sting. No report of Yellow jacket sting is found in people who take Novalgin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Novalgin?
Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 8,699 Novalgin users for its effectiveness, alternative drugs and more.
What is Yellow Jacket Sting?
Yellow jacket sting: no further information found.
Do you take Novalgin and have Yellow jacket sting?Check whether Yellow jacket sting is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Yellow jacket sting and when was it recovered:
Expand to all the drugs that have ingredients of metamizole:
Alternative drugs to, pros and cons of Novalgin:
- Novalgin (8,699 reports)
Yellow jacket sting treatments and more:
- Yellow jacket sting (123 reports)
COVID vaccines that are related to Yellow jacket sting:
- Yellow jacket sting in Moderna COVID Vaccine
- Yellow jacket sting in Pfizer BioNTech Covid Vaccine
- Yellow jacket sting in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Yellow jacket sting:
All the conditions that are associated with Yellow jacket sting:
How the study uses the data?
The study uses data from the FDA. It is based on metamizole (the active ingredients of Novalgin) and Novalgin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Buspar and Renal Failure Chronic - 6 seconds ago
- Daliresp and Zylet drug interaction - 14 seconds ago
- Pepcid and Ciclopirox drug interaction - 15 seconds ago
- Cimzia and Facial Paralysis - 15 seconds ago
- Forteo and Oesophageal Dilatation - 18 seconds ago
- Leucovorin Calcium and Raptiva drug interaction - 22 seconds ago
- Cyclophosphamide and Peritoneal Perforation - 27 seconds ago
- Cerebral Palsy and Muscle Rigidity - 28 seconds ago
- Zoladex and Haemorrhagic Stroke - 32 seconds ago
- Symbicort and Scotoma - 32 seconds ago